Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGA4 | P13612 | 9/20 | 0.47 |
| ▸ | ITGB1 | P05556 | 8/20 | 0.47 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.44 |
| ▸ | CTSA | P10619 | 5/20 | 0.43 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7646241 | 1.00 | ITGA4 (0.47) | ITGA4ITGB1ITGB7CTSATAS1R3 | |
| SCHEMBL7651698 | 0.96 | ITGB1 (0.49) | ITGA4ITGB1ITGB7CTSATAS1R3 | |
| SCHEMBL7651701 | 0.96 | ITGB1 (0.49) | ITGA4ITGB1ITGB7CTSATAS1R3 | |
| SCHEMBL7422471 | 0.93 | ITGB1 (0.49) | ITGA4ITGB1ITGB7CTSATAS1R3 | |
| SCHEMBL7644620 | 0.93 | ITGB1 (0.49) | ITGA4ITGB1ITGB7CTSATAS1R3 | |
| SCHEMBL7646186 | 0.90 | ITGB1 (0.45) | ITGA4ITGB1ITGB7TAS1R3TAS1R1 | |
| SCHEMBL7646191 | 0.90 | ITGB1 (0.45) | ITGA4ITGB1ITGB7TAS1R3TAS1R1 | |
| SCHEMBL5700984 | 0.90 | ITGB1 (0.51) | ITGA4ITGB1ITGB7CTSAMEN1 | |
| SCHEMBL5700989 | 0.90 | ITGB1 (0.51) | ITGA4ITGB1ITGB7CTSAMEN1 | |
| SCHEMBL5700993 | 0.89 | ITGB1 (0.51) | ITGA4ITGB1ITGB7CTSAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6479519-B1 | INHIBITORS OF CELL ADHESION; TREATMENT OF ASTHMA OR INFLAMMATORY BOWEL DISEASE | AVENTIS PHARMA LIMITED (GB) | 2002-11-12 | — | — | US | claimed |
| US-6479519-B1 | INHIBITORS OF CELL ADHESION; TREATMENT OF ASTHMA OR INFLAMMATORY BOWEL DISEASE | AVENTIS PHARMA LIMITED (GB) | 2002-11-12 | — | — | US | disclosed |